Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Genfit S.A. ADR (NQ: GNFT ) 4.500 -0.030 (-0.66%) Streaming Delayed Price Updated: 3:59 PM EST, Nov 15, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Genfit S.A. ADR < Previous 1 2 3 4 Next > Baidu, XPeng And Other Big Stocks Moving Lower In Monday's Pre-Market Session October 14, 2024 Via Benzinga Top 4 Health Care Stocks That May Keep You Up At Night September 24, 2024 Via Benzinga Why Nike Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket September 20, 2024 Via Benzinga FDA Fast-Tracks Ipsen And Genfit's New Liver Disease Treatment, Iqirvo June 11, 2024 The U.S. FDA has granted accelerated approval for Iqirvo, a novel drug from Ipsen SA and Genfit SA, designed for treating primary biliary cholangitis (PBC). This approval, based on the drug's ability... Via Benzinga Exposures Product Safety Analyst Expectations for Genfit's Future July 03, 2023 Via Benzinga Genfit To Buy This Swiss Firm Expanding Its Portfolio in Liver Diseases September 19, 2022 Via Benzinga Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session May 31, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session May 31, 2024 Via Benzinga Why Zscaler Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket May 31, 2024 Via Benzinga Earnings Scheduled For April 4, 2024 April 04, 2024 Companies Reporting Before The Bell • Conagra Brands (NYSE:CAG) is likely to report quarterly earnings at $0.65 per share on revenue of $3.01 billion. Via Benzinga Why CymaBay Morphed From Dollar Stock To Biotech Rocket December 28, 2023 The company is working on the first treatment that could make a difference in the itching associated with a liver disease. Via Investor's Business Daily 12 Health Care Stocks Moving In Tuesday's Pre-Market Session November 14, 2023 Via Benzinga Why CymaBay, With 172% Growth This Year, Just Surged For A Second Day Running September 08, 2023 The company is working on a treatment for a liver disease that can cause severe itching. Via Investor's Business Daily Intercept Pharma Gets Double Upgrade: Analyst Says OCA Combo Therapy Can Extend PBC Business July 13, 2023 HC Wainwright has upgraded Intercept Pharmaceuticals Inc (NASDAQ: ICPT) to Buy from Sell, with a price target of Via Benzinga Genfit's Miss Is CymaBay Therapeutics' Gain: Analyst Says Rival Data Leaves Room for Seladelpar To Emerge As Best-In-Class June 30, 2023 Friday, CymaBay Therapeutics Inc's (NASDAQ: CBAY) competitors Genfit SA (NASDAQ: GNFT) and Ipsen SA (OTC: Via Benzinga Ipsen, Genfit's Elafibranor Shows Promise In Primary Biliary Cholangitis Patients June 30, 2023 Ipsen SA (OTC: IPSEY) and Genfit SA (NASDAQ: GNFT) Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session June 30, 2023 Via Benzinga Why Renalytix Are Trading Higher By Over 48%; Here Are 20 Stocks Moving Premarket June 30, 2023 Gainers Renalytix Plc (NASDAQ: RNLX) shares surged 48.7% to $3.02 in pre-market trading after the company received FDA De Novo marketing authorization for its KidneyIntelX.dkd prognostic test. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday June 30, 2023 It's the final day of trading this week and we're starting off with a breakdown of the biggest pre-market stock movers worth watching today! Via InvestorPlace Former Wall Street Darling Intercept Restructures After FDA Rejects Its Liver Drug June 23, 2023 Following the FDA rejection, Intercept will restructure to focus on rare liver diseases. Via Investor's Business Daily 12 Health Care Stocks Moving In Thursday's Pre-Market Session June 22, 2023 Via Benzinga What Now After FDA AdComm Rebuke for Intercept Pharmaceutical? Analyst Says Approval Of Intercept's 'OCA In NASH May Never Occur May 22, 2023 On Friday, FDA's Gastrointestinal Drugs Advisory Committee voted 12 to 2—with two abstentions—that the benefits of Intercept Pharmaceutical Inc's ICPT Ocaliva 25 mg, also known as Obeticholic acid... Via Benzinga Earnings Scheduled For April 13, 2023 April 13, 2023 Companies Reporting Before The Bell • Northern Technologies (NASDAQ:NTIC) is estimated to report quarterly earnings at $0.18 per share on revenue of $20.40 million. Via Benzinga The 7 Best Biotech Stocks to Buy for February 2023 February 07, 2023 Following the wave of red ink last year, astute investors should target the best biotech stocks to buy this month for strong growth potential. Via InvestorPlace 12 Health Care Stocks Moving In Monday's Pre-Market Session October 10, 2022 Gainers NeuroMetrix (NASDAQ:NURO) shares increased by 23.0% to $3.48 during Monday's pre-market session. The company's market cap stands at $24.8 million. Via Benzinga Earnings Scheduled For September 28, 2022 September 28, 2022 Companies Reporting Before The Bell • Lilium (NASDAQ:LILM) is expected to report earnings for its second quarter. Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session September 22, 2022 Gainers Genfit (NASDAQ:GNFT) shares increased by 27.4% to $5.12 during Thursday's after-market session. The market value of their outstanding shares is at $255.0 million. Via Benzinga US Stock Futures Rise After Recording Worst Sell-Off Since June 2020; PPI Data In Focus September 14, 2022 Pre-open movers U.S. stock futures traded higher in early pre-market trade on Wednesday after recording sharp losses on Tuesday following the release of inflation data for August. All the three major... Via Benzinga BRP, Conformis And 3 Stocks To Watch Heading Into Wednesday September 14, 2022 With US stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Via Benzinga Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary September 13, 2022 Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
